Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.91 USD | +1.27% | +7.03% | +38.72% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
REVOLUTION MEDICINES, INC. | Other Biotechnology & Medical Research | +0.95% | +7.03% | +38.72% | +49.06% | - | 6.5B |
Technical Rankings Surperformance
- Stock Market
- Equities
- RVMD Stock
- Charts Revolution Medicines, Inc.
- Comparison Chart